🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Evidence thus suggests that steroid administration, tight glucose control, ...
Status
Terminated
Location
Cleveland Clinic
Start Date
2007-01
Trial ID
NCT00995501
A protocol named as "HLH-DR" for patients with refractory and secondary hem...
Status
Unknown
Location
Yan Yue
Start Date
2017-03-01
Trial ID
NCT03795909
Treatments Being Tested
The aim of this trial is to evaluate whether testosterone replacement resul...
Status
Completed
Location
Brigham and Women's Hospital
Start Date
2022-11-15
Trial ID
NCT04895306
Treatments Being Tested
This is a randomised, controlled, open, two-armed, two-period cross-over, m...
Status
Completed
Location
Multiple Locations
Start Date
2007-08-21
Trial ID
NCT00915343
Treatments Being Tested
To see if megestrol acetate plus Levonorgestrel-releasing intrauterine syst...
Status
Completed
Location
Obstetrics and Gynecology Hospital, Fudan University
Start Date
2017-07-04
Trial ID
NCT03241914
Treatments Being Tested
The primary purpose of this study is to determine the effects of a full dos...
Status
Unknown
Location
Centre for Menstrual Cycle and Ovulation Research
Start Date
2005-09
Trial ID
NCT00152438
Treatments Being Tested
The purpose of this trial is to study the efficacy and safety of low dose o...
Status
Completed
Location
Multiple Locations
Start Date
1998-02
Trial ID
NCT00860964
Treatments Being Tested
This Pilot study will investigate the bioavailability in fasting women of 2...
Status
Completed
Location
Innolab
Start Date
2019-11-09
Trial ID
NCT04193852
Objective: To study the influence of metabolic factors on the action of pro...
Status
Completed
Location
Multiple Locations
Start Date
2014-02-10
Trial ID
NCT05062135
Treatments Being Tested
This study consists of two parts. Part 1 is a dose-escalation/safety evalua...
Status
Terminated
Location
University of Alabama at Birmingham
Start Date
2017-05-12
Trial ID
NCT03134638